Capsulomics, Inc is a molecular diagnostics company structured around early detection of cancer through preventive screening: identifying early stage condition while the propsects of successful treatment are optimum. Typically, - due to the high cost and limited availability of the available cancer detection methods - evluation is rarely undertaken before symptoms are present ...and often too late for life-saving intervention. Capsulomics seeks to bring a proactive market solution that is much cheaper and less invasive, allowing administration in any doctor's office. rather than requiring an endoscopy suite or operating room. In a study to detect esophageal cancer and its precancerous precursor condition, Barrett's esophagus (BE), in collboration with Johns Hopkins University - a global leader in the research space of of cancer diagnostics - the effort is a study - a major step toward bringing a low-cost, less invasive, proactive test to market to allow earlier detection and more life-saving measures.
